Cornerstone Financial Management’s Avidity Biosciences RNAM Stock Holding History

Cornerstone Financial Management’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-11	Closed	-$793	–	1373
2025 Q4	$793	Buy	+11	New	+$711	﹤0.01%	1007

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Cornerstone Financial Management's RNAM Position: Q1 2026 in Review

Cornerstone Financial Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 11 shares — an estimated $793 sold.

Cornerstone Financial Management first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $793 in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Cornerstone Financial Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Cornerstone Financial Management sold 11 Avidity Biosciences shares in Q1 2026, an estimated $793.
Cornerstone Financial Management first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
Cornerstone Financial Management's Avidity Biosciences position peaked at $793 in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Cornerstone Financial Management's 13F filing for Q1 2026, filed 8 May 2026.